- Filed
- Feb 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jan 31, 2025 | 13.19M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $20.21M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $62.72M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $110.64M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $71M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $163.56M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $128.11M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $159.02M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $179.96M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $272.5M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $293.9M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 18.44M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 18.67M sh |
| Stock Repurchased | Q2 2025 · Dec 31, 2023 | $10.27M |
| Capex | Q2 2025 · Dec 31, 2023 | $4.94M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $7.05M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $156.11M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $156.04M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $149.96M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.33 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.72 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.34 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.75 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $24.86M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $47.9M |
| Net Income | Q2 2025 · Dec 31, 2023 | $6.08M |
| Net Income | Q2 2025 · Dec 31, 2023 | $13.5M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $6.95M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $15.28M |
| Revenue | Q2 2025 · Dec 31, 2023 | $132.63M |
| Revenue | Q2 2025 · Dec 31, 2023 | $257.24M |